Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of 35.99% is in line with its 5-year average of 34.08%, around the middle of its 5-year range (28.32%–40.52%).
5.30% below its 12-month average of 38.00%.
Reported quarterly EBITDA margin; no daily interpolation.
EBITDA MARGIN
35.99%
EBITDA MARGIN AVG TTM
38.00%
EBITDA MARGIN AVG 3Y
34.66%
EBITDA MARGIN AVG 5Y
34.08%
EBITDA MARGIN AVG 10Y
35.03%
EBITDA MARGIN AVG 15Y
36.14%
EBITDA MARGIN AVG 20Y
36.57%
CURRENT VS TTM AVG
-5.30%
CURRENT VS 3Y AVG
+3.84%
CURRENT VS 5Y AVG
+5.59%
CURRENT VS 10Y AVG
+2.73%
CURRENT VS 15Y AVG
-0.41%
CURRENT VS 20Y AVG
-1.57%
Intuitive Surgical, Inc.
Market Cap
$123.75B
EBITDA Margin
35.99%
TTM Avg
38.00%
3Y Avg
34.66%
5Y Avg
34.08%
Market Cap
$132.20B
EBITDA Margin
36.80%
TTM Avg
38.33%
3Y Avg
39.88%
5Y Avg
39.69%
Market Cap
$134.32B
EBITDA Margin
41.14%
TTM Avg
20.45%
3Y Avg
32.86%
5Y Avg
36.27%
Market Cap
$106.92B
EBITDA Margin
24.22%
TTM Avg
25.63%
3Y Avg
25.70%
5Y Avg
26.23%
Market Cap
$105.63B
EBITDA Margin
1.78%
TTM Avg
1.58%
3Y Avg
1.64%
5Y Avg
1.66%
Market Cap
$144.70B
EBITDA Margin
30.87%
TTM Avg
31.21%
3Y Avg
32.47%
5Y Avg
31.98%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Intuitive Surgical, Inc. (ISRG) | $123.75B | 35.99% | 38.00% | 34.66% | 34.08% |
| CVS Health Corp. (CVS)vs › | $122.94B | 3.73% | 3.63% | 4.02% | 4.83% |
| Medtronic plc (MDT)vs › | $118.19B | 25.92% | 26.11% | 25.62% | 25.51% |
| Bristol-Myers Squibb Company (BMY)vs › | $132.20B | 36.80% | 38.33% | 39.88% | 39.69% |
| Vertex Pharmaceuticals Incorporated (VRTX)vs › | $134.32B | 41.14% | 20.45% | 32.86% | 36.27% |
| Stryker Corporation (SYK)vs › | $106.92B | 24.22% | 25.63% | 25.70% | 26.23% |
| McKesson Corporation (MCK)vs › | $105.63B | 1.78% | 1.58% | 1.64% | 1.66% |
| Sanofi (SNY)vs › | $104.00B | 32.70% | 28.59% | 29.32% | 32.36% |
| Danaher Corporation (DHR)vs › | $144.70B | 30.87% | 31.21% | 32.47% | 31.98% |
| GSK plc (GSK)vs › | $97.44B | 32.61% | 26.78% | 28.16% | 28.64% |
Gross Margin
66.7%
EBITDA Margin
36.0%
Operating Margin
31.3%
Net Margin
28.4%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-06-30 | 40.52% |
| 2026-03-31 | 38.09% |
| 2025-12-31 | 37.86% |
| 2025-09-30 | 36.71% |
| 2025-06-30 | 36.83% |
| 2025-03-31 | 31.91% |
| 2024-12-31 | 35.62% |
| 2024-09-30 | 34.03% |
| 2024-06-30 | 33.79% |
| 2024-03-31 | 30.61% |
| 2023-12-31 | 29.74% |
| 2023-09-30 | 32.94% |
| 2023-06-30 | 31.92% |
| 2023-03-31 | 28.32% |
| 2022-12-31 | 28.92% |
| 2022-09-30 | 31.38% |
| 2022-06-30 | 31.77% |
| 2022-03-31 | 33.06% |
| 2021-12-31 | 34.26% |
| 2021-09-30 | 37.39% |
| 2021-06-30 | 40.08% |
| 2021-03-31 | 37.81% |
| 2020-12-31 | 37.29% |
| 2020-09-30 | 31.51% |
| 2020-06-30 | 16.95% |
| 2020-03-31 | 31.51% |
| 2019-12-31 | 36.11% |
| 2019-09-30 | 36.93% |
| 2019-06-30 | 36.92% |
| 2019-03-31 | 30.17% |
| 2018-12-31 | 35.19% |
| 2018-09-30 | 37.39% |
| 2018-06-30 | 33.72% |
| 2018-03-31 | 35.75% |
| 2017-12-31 | 39.74% |
| 2017-09-30 | 37.65% |
| 2017-06-30 | 37.21% |
| 2017-03-31 | 31.77% |
| 2016-12-31 | 38.12% |
| 2016-09-30 | 40.81% |
| 2016-06-30 | 39.95% |
| 2016-03-31 | 34.05% |
| 2015-12-31 | 39.99% |
| 2015-09-30 | 36.20% |
| 2015-06-30 | 33.25% |
| 2015-03-31 | 28.30% |
| 2014-12-31 | 34.13% |
| 2014-09-30 | 32.54% |
| 2014-06-30 | 31.28% |
| 2014-03-31 | 15.84% |
| 2013-12-31 | 39.34% |
| 2013-09-30 | 38.24% |
| 2013-06-30 | 40.64% |
| 2013-03-31 | 43.70% |
| 2012-12-31 | 43.25% |
| 2012-09-30 | 42.13% |
| 2012-06-30 | 44.59% |
| 2012-03-31 | 41.72% |
| 2011-12-31 | 42.67% |
| 2011-09-30 | 42.62% |
| 2011-06-30 | 42.12% |
| 2011-03-31 | 41.12% |
| 2010-12-31 | 42.26% |
| 2010-09-30 | 41.35% |
| 2010-06-30 | 42.63% |
| 2010-03-31 | 42.36% |
| 2009-12-31 | 42.43% |
| 2009-09-30 | 40.50% |
| 2009-06-30 | 41.63% |
| 2009-03-31 | 28.15% |
| 2008-12-31 | 38.97% |
| 2008-09-30 | 38.91% |
| 2008-06-30 | 38.49% |
| 2008-03-31 | 36.93% |
| 2007-12-31 | 40.70% |
| 2007-09-30 | 36.57% |
| 2007-06-30 | 34.30% |
| 2007-03-31 | 32.56% |
| 2006-12-31 | 56.63% |
| 2006-09-30 | 29.51% |
| 2006-06-30 | 30.68% |
| 2006-03-31 | 30.94% |
| 2005-12-31 | 35.10% |
| 2005-09-30 | 37.20% |
| 2005-06-30 | 32.16% |
| 2005-03-31 | 25.43% |
| 2004-12-31 | 28.10% |
| 2004-09-30 | 20.31% |
| 2004-06-30 | 20.12% |
| 2004-03-31 | 7.90% |
| 2003-12-31 | 0.96% |
| 2003-09-30 | -6.33% |
| 2003-06-30 | 8.69% |
| 2003-03-31 | -9.88% |
| 2002-12-31 | -8.61% |
| 2002-09-30 | -33.15% |
